Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model

AIM: To clarify the mechanism of infliximab treatment in diabetic macular edema (DME) and to provide a new alternative therapy for DME. METHODS: Rats were randomly divided into the control group, the model group and the infliximab treatment group. A diabetic rat model was created. The concentration...

Full description

Bibliographic Details
Main Authors: Mao-Song Xie, Yong-Zheng Zheng, Li-Bin Huang, Guo-Xing Xu
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2017-12-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.cn/en_publish/2017/12/20171206.pdf

Similar Items